These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 28713943)

  • 21. Compatibility of Tanshinone IIA and Astragaloside IV in attenuating hypoxia-induced cardiomyocytes injury.
    Wang D; Liu Y; Zhong G; Wang Y; Zhang T; Zhao Z; Yan X; Liu Q
    J Ethnopharmacol; 2017 May; 204():67-76. PubMed ID: 28389356
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reversal effect of bufalin on multidrug resistance in human hepatocellular carcinoma BEL-7402/5-FU cells.
    Gu W; Liu L; Fang FF; Huang F; Cheng BB; Li B
    Oncol Rep; 2014 Jan; 31(1):216-22. PubMed ID: 24173654
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Astragaloside IV prevents high glucose-induced podocyte apoptosis via downregulation of TRPC6.
    Yao XM; Liu YJ; Wang YM; Wang H; Zhu BB; Liang YP; Yao WG; Yu H; Wang NS; Zhang XM; Peng W
    Mol Med Rep; 2016 Jun; 13(6):5149-56. PubMed ID: 27109610
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SH3GL1 inhibition reverses multidrug resistance in colorectal cancer cells by downregulation of MDR1/P-glycoprotein via EGFR/ERK/AP-1 pathway.
    Guan H; Zhao P; Dai Z; Liu X; Wang X
    Tumour Biol; 2016 Sep; 37(9):12153-12160. PubMed ID: 27220321
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Silencing the EZH2 gene by RNA interference reverses the drug resistance of human hepatic multidrug-resistant cancer cells to 5-Fu.
    Zhang Y; Liu G; Lin C; Liao G; Tang B
    Life Sci; 2013 May; 92(17-19):896-902. PubMed ID: 23562851
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oroxylin A reverses multi-drug resistance of human hepatoma BEL7402/5-FU cells via downregulation of P-glycoprotein expression by inhibiting NF-κB signaling pathway.
    Yang HY; Zhao L; Yang Z; Zhao Q; Qiang L; Ha J; Li ZY; You QD; Guo QL
    Mol Carcinog; 2012 Feb; 51(2):185-95. PubMed ID: 21557331
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Opsin3 sensitizes hepatocellular carcinoma cells to 5-fluorouracil treatment by regulating the apoptotic pathway.
    Jiao J; Hong S; Zhang J; Ma L; Sun Y; Zhang D; Shen B; Zhu C
    Cancer Lett; 2012 Jul; 320(1):96-103. PubMed ID: 22313545
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Icariin enhances cytotoxicity of doxorubicin in human multidrug-resistant osteosarcoma cells by inhibition of ABCB1 and down-regulation of the PI3K/Akt pathway.
    Wang Z; Yang L; Xia Y; Guo C; Kong L
    Biol Pharm Bull; 2015; 38(2):277-84. PubMed ID: 25747987
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synergistic effect of cucurbitacin B in combination with curcumin via enhancing apoptosis induction and reversing multidrug resistance in human hepatoma cells.
    Sun Y; Zhang J; Zhou J; Huang Z; Hu H; Qiao M; Zhao X; Chen D
    Eur J Pharmacol; 2015 Dec; 768():28-40. PubMed ID: 26452516
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Unfolded protein response mediated JNK/AP-1 signal transduction, a target for ovarian cancer treatment.
    Zheng GF; Cai Z; Meng XK; Zhang Y; Zhu W; Pang XY; Dou L
    Int J Clin Exp Pathol; 2015; 8(6):6505-11. PubMed ID: 26261528
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MG‑132 reverses multidrug resistance by activating the JNK signaling pathway in FaDu/T cells.
    Ma J; Lv Z; Liu X; Liu X; Xu W
    Mol Med Rep; 2018 Aug; 18(2):1820-1825. PubMed ID: 29901180
    [TBL] [Abstract][Full Text] [Related]  

  • 32. H1, a derivative of tetrandrine, enhances the efficacy of 5-FU in Bel7402/5-FU cells via suppressing STAT3/MCL-1 and inducing PUMA.
    Li F; Wang J; Wu N; Zhang H; Li Z; Wei N
    Biochem Biophys Res Commun; 2019 Nov; 520(1):93-98. PubMed ID: 31582208
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thimerosal induces apoptosis in a neuroblastoma model via the cJun N-terminal kinase pathway.
    Herdman ML; Marcelo A; Huang Y; Niles RM; Dhar S; Kiningham KK
    Toxicol Sci; 2006 Jul; 92(1):246-53. PubMed ID: 16624850
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Suppression of MDR1 expression and restoration of sensitivity to chemotherapy in multidrug-resistant hepatocellular carcinoma cell line Bel7402/5-Fu by RNA interference].
    Ren YY
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Dec; 31(6):872-6. PubMed ID: 17213586
    [TBL] [Abstract][Full Text] [Related]  

  • 35. P-glycoprotein Inhibitor Tariquidar Potentiates Efficacy of Astragaloside IV in Experimental Autoimmune Encephalomyelitis Mice.
    Zhang W; Liu M; Yang L; Huang F; Lan Y; Li H; Wu H; Zhang B; Shi H; Wu X
    Molecules; 2019 Feb; 24(3):. PubMed ID: 30717494
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metformin and AICAR regulate NANOG expression via the JNK pathway in HepG2 cells independently of AMPK.
    Shen C; Ka SO; Kim SJ; Kim JH; Park BH; Park JH
    Tumour Biol; 2016 Aug; 37(8):11199-208. PubMed ID: 26939902
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Astragaloside IV prevents damage to human mesangial cells through the inhibition of the NADPH oxidase/ROS/Akt/NF‑κB pathway under high glucose conditions.
    Sun L; Li W; Li W; Xiong L; Li G; Ma R
    Int J Mol Med; 2014 Jul; 34(1):167-76. PubMed ID: 24718766
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Central Role for JNK/AP-1 Pathway in the Pro-Oxidant Effect of Pyrrolidine Dithiocarbamate through Superoxide Dismutase 1 Gene Repression and Reactive Oxygen Species Generation in Hematopoietic Human Cancer Cell Line U937.
    Riera H; Afonso V; Collin P; Lomri A
    PLoS One; 2015; 10(5):e0127571. PubMed ID: 25996379
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reversal effect of melanoma differentiation associated gene-7/interleukin-24 on multidrug resistance in human hepatocellular carcinoma cells.
    Fang P; Zhang X; Gao Y; Ding CR; Cui F; Jiao SC
    Anat Rec (Hoboken); 2012 Oct; 295(10):1639-46. PubMed ID: 22899557
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Astragaloside IV inhibits breast cancer cell invasion by suppressing Vav3 mediated Rac1/MAPK signaling.
    Jiang K; Lu Q; Li Q; Ji Y; Chen W; Xue X
    Int Immunopharmacol; 2017 Jan; 42():195-202. PubMed ID: 27930970
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.